Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

1.

Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.

Righi A, Morandi L, Leonardi E, Farnedi A, Marucci G, Sisto A, Frank G, Faustini-Fustini M, Zoli M, Mazzatenta D, Agati R, Foschini MP.

Hum Pathol. 2013 Nov;44(11):2400-9. doi: 10.1016/j.humpath.2013.05.020. Epub 2013 Sep 2.

PMID:
24007691
2.

Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.

Sánchez-Tejada L, Sánchez-Ortiga R, Moreno-Pérez O, Montañana CF, Niveiro M, Tritos NA, Alfonso AM.

Endocrinol Nutr. 2013 Aug-Sep;60(7):358-67. doi: 10.1016/j.endonu.2012.09.005. Epub 2013 Feb 15.

PMID:
23416216
3.

Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.

Yamada S, Takahashi M, Hara M, Hattori A, Sano T, Ozawa Y, Shishiba Y, Hirata K, Usui M.

Clin Endocrinol (Oxf). 1996 Sep;45(3):263-72.

PMID:
8949563
4.

Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.

Coli A, Asa SL, Fadda G, Scannone D, Chiloiro S, De Marinis L, Lauretti L, Ranelletti FO, Lauriola L.

Eur J Endocrinol. 2016 Mar;174(3):307-14. doi: 10.1530/EJE-15-0586. Epub 2015 Nov 30.

5.

Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas.

Jin L, Riss D, Ruebel K, Kajita S, Scheithauer BW, Horvath E, Kovacs K, Lloyd RV.

Endocr Pathol. 2005 Summer;16(2):107-14.

PMID:
16199895
6.

RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.

Zhang HY, Jin L, Stilling GA, Ruebel KH, Coonse K, Tanizaki Y, Raz A, Lloyd RV.

Endocrine. 2009 Feb;35(1):101-11. doi: 10.1007/s12020-008-9129-z. Epub 2008 Nov 20.

7.

Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.

Ruebel KH, Leontovich AA, Jin L, Stilling GA, Zhang H, Qian X, Nakamura N, Scheithauer BW, Kovacs K, Lloyd RV.

Endocrine. 2006 Jun;29(3):435-44.

PMID:
16943582
9.

Expression of FOXL2 in human normal pituitaries and pituitary adenomas.

Egashira N, Takekoshi S, Takei M, Teramoto A, Osamura RY.

Mod Pathol. 2011 Jun;24(6):765-73. doi: 10.1038/modpathol.2010.169. Epub 2011 Apr 8.

11.

[Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].

Brito J, Sáez L, Lemp M, Liberman C, Michelsen H, Araya AV.

Rev Med Chil. 2008 Jul;136(7):831-6. doi: /S0034-98872008000700002. Epub 2008 Sep 4. Spanish.

12.
13.

Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas.

Ikuyama S, Mu YM, Ohe K, Nakagaki H, Fukushima T, Takayanagi R, Nawata H.

Clin Endocrinol (Oxf). 1998 May;48(5):647-54.

PMID:
9666878
14.

Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.

Kim K, Arai K, Sanno N, Osamura RY, Teramoto A, Shibasaki T.

Clin Endocrinol (Oxf). 2001 Jun;54(6):759-68.

PMID:
11422110
15.

Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.

Shao S, Li X.

J Neurosurg Sci. 2013 Sep;57(3):267-75.

PMID:
23877272
16.

Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.

Gaffey TA Jr, Scheithauer BW, Leech RW, Blick K, Kovacs K, Horvath E, Weaver AL, Lloyd RV, Ebersold M, Laws ER Jr, DeBault LE.

Clin Neuropathol. 2005 Mar-Apr;24(2):56-63.

PMID:
15803804
17.

[Non-functioning pituitary adenomas: clinical features and immunohistochemistry].

Ferreira JE, de Mello PA, de Magalhães AV, Botelho CH, Naves LA, Nosé V, Schmitt F.

Arq Neuropsiquiatr. 2005 Dec;63(4):1070-8. Epub 2005 Dec 15. Portuguese.

18.

Immunohistochemical detection of human natural killer cell like immunoreactivity in human pituitary adenomas, using monoclonal antibody NK-1.

Sanno N, Itoh J, Teramoto A, Itoh Y, Hori S, Osamura RY.

J Neurooncol. 1997 Oct;35(1):29-38.

PMID:
9266438
19.

[The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].

Asano K, Kubo O, Tajika Y, Huang MC, Takakura K.

No To Shinkei. 1996 Jun;48(6):543-9. Japanese.

PMID:
8703557
20.

Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.

Chiloiro S, Doglietto F, Trapasso B, Iacovazzo D, Giampietro A, Di Nardo F, de Waure C, Lauriola L, Mangiola A, Anile C, Maira G, De Marinis L, Bianchi A.

Neuroendocrinology. 2015;101(2):143-50. doi: 10.1159/000375448. Epub 2015 Jan 29.

PMID:
25633744

Supplemental Content

Support Center